Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-25-175420
Filing Date
2025-08-07
Accepted
2025-08-07 16:05:24
Documents
4
Period of Report
2025-08-07

Document Format Files

Seq Description Document Type Size
1 6-K d61138d6k.htm 6-K 9422
2 EX-99.1 d61138dex991.htm EX-99.1 128472
3 GRAPHIC g61138g32r60.jpg GRAPHIC 1559
4 GRAPHIC g61138g89g88.jpg GRAPHIC 3926
  Complete submission text file 0001193125-25-175420.txt   146820
Mailing Address TUBORG BOULEVARD 12 HELLERUP Denmark
Business Address TUBORG BOULEVARD 12 HELLERUP Denmark 45 70 22 22 44
Ascendis Pharma A/S (Filer) CIK: 0001612042 (see all company filings)

EIN.: 000000000 | State of Incorp.: G7 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-36815 | Film No.: 251193883
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)